- Report
- April 2026
- 30 Pages
Global
From €2527EUR$2,750USD£2,110GBP
- Report
- April 2026
- 30 Pages
Global
From €2527EUR$2,750USD£2,110GBP
- Report
- March 2026
- 30 Pages
Global
From €2527EUR$2,750USD£2,110GBP
- Report
- March 2026
- 150 Pages
Global
From €3447EUR$3,750USD£2,877GBP
- Report
- January 2026
- 400 Pages
Global
From €4595EUR$5,000USD£3,836GBP
- Report
- January 2026
- 180 Pages
Global
From €2757EUR$3,000USD£2,302GBP
- Report
- January 2026
- 450 Pages
Global
From €4595EUR$5,000USD£3,836GBP
- Report
- January 2026
- 450 Pages
Global
From €4595EUR$5,000USD£3,836GBP
- Report
- December 2025
- 200 Pages
Global
From €7307EUR$7,950USD£6,100GBP
- Report
- August 2026
- 110 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 110 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 140 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 110 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 140 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 185 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- September 2026
- 196 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- August 2026
- 119 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- August 2026
- 111 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- August 2026
- 111 Pages
Global
From €4366EUR$4,750USD£3,644GBP
- Report
- August 2026
- 112 Pages
Global
From €4366EUR$4,750USD£3,644GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more